Global Pharmaceutical R&D Directory 2024: Development Pipeline of Major Companies Analyzed by Therapeutic Categories and Stages.(research & development)
| Published date | 12 March 2024 |
M2 PRESSWIRE-March 12, 2024-: Global Pharmaceutical R&D Directory 2024: Development Pipeline of Major Companies Analyzed by Therapeutic Categories and Stages
(C)1994-2024 M2 COMMUNICATIONS
RDATE:12032024
The "Global Pharmaceutical R&D Directory 2024" has been added to ResearchAndMarkets.com's offering.The Global Pharmaceutical R&D Directory provides a wealth of key business data on trends in pharmaceutical research. At a time when investment in R&D is at an all-time high, this essential publication is intended as a strategic reference guide to the important trends in pharmaceutical R&D, as well as providing the means to benchmark your company's performance.From an examination of global R&D investment and productivity to a breakdown of R&D trends in every major therapeutic class, The R&D Directory provides a comprehensive review of the current R&D environment.The R&D Directory provides essential time-saving business information on:
The development pipeline of major companies is analyzed by therapeutic categories and stages
Compounds in research by therapeutic class for major companies
Number of licensed compounds by therapeutic class and development stage
Comparison of companies' licensed/originated product pipelines
Average development time to market, and attrition data
Trends in global R&D investment, cost, and culture
Number of biotechnology products by development phase, therapeutic class, and type
Plus much, much more!
Key Features:
Trends in licensing for major pharmaceutical companies
R&D Focus for key therapy areas
Benchmark development time by phase and success for over dozens of therapeutic categories
Comparisons of compounds in research by development stage for dozens of therapeutic areas
Analysis of previous year's pipeline development by stage for all major pharmaceutical companies worldwide.
Report Scope:
Section 1 & 2 of The R&D Directory looks at the trends in R&D expenditure in the major markets, changes in employment patterns and productivity levels in relation to pharmaceutical sales.
Section 3 reviews the outsourcing industry and...
To continue reading
Request your trial